In advanced stages of cancer, CRC cells release TGF-β, which inhibits the differentiation of immature T cells into Th1 cells, encourages their conversion into Treg subsets, and impairs the antigen-presenting activity of dendritic cells, facilitating immune evasion. The gene discussed is TGFB1; the disease is cancer.